Growing global burden of type 1 diabetes needs multitiered precision public health interventions

Diabetes is a public health crisis, and diabetes-related health and economic burdens have been rising globally over the past decades, with the growth being the most striking in low-income and middle-income countries (LMICs).1 Most studies in estimating diabetes burdens have been focused on type 2 diabetes with scarce evidence on type 1 diabetes.2 Type 1 diabetes faces the challenges of misdiagnosis, underdiagnosis, high risk of complications, and premature mortality.3